X-Biotix Therapeutics
Waltham, US · Founded 2016 · Delaware corporation
Founders & leadership
RV
Ramani VaranasiExecutive
DC
David Cook, Ph.D.Named on SEC filing
CD
Christopher D. RayNamed on SEC filing
ST
Stephen T. IsaacsNamed on SEC filing
Reported raises · per SEC filings
Form D private placements$13.4M disclosed across 2 rounds · 2018–2019
▶$4MraisedNov 2019 · 7 investors · BiotechnologyRule 506(b)
▶$4MraisedNov 2019 · 7 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Stephen T. IsaacsDirector
- Christopher D. RayDirector
- Ramani VaranasiExecutive Officer, Director
- David Cook, Ph.D.Director
- Dominic RyanExecutive Officer
- Offering amount
- $4M
- Amount sold
- $4M
- First sale
- Nov 2019
- Incorporated
- Corporation, Delaware, 2016
- Federal exemptions
- 06b
▶$9.4MraisedJun 2019 · 7 investors · BiotechnologyRule 506(b)
▶$9.4MraisedJun 2019 · 7 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Ramani VaranasiExecutive Officer, Director
- David Cook, Ph.D.Director
- Christopher D. RayDirector
- Stephen T. IsaacsDirector
- Offering amount
- $9.4M
- Amount sold
- $9.4M
- First sale
- Apr 2018
- Incorporated
- Corporation, Delaware, 2016
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
In the news
Frequently asked questions
- How much funding has X-Biotix Therapeutics raised?
- X-Biotix Therapeutics has disclosed $13.4M raised across 2 rounds.
- Where is X-Biotix Therapeutics headquartered?
- X-Biotix Therapeutics is headquartered in Waltham, US.